Hepagene Therapeutics (HK) Limited

Organization

Hong Kong, CN

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Urea derivatives as inhibitors of ASK1
- Patent number 11,427,556
- Issue date Aug 30, 2022
- Hepagene Therapeutics (HK) Limited
- Xiaodong Xu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nitrogen-containing heterocyclic compounds as FXR modulators
- Patent number 10,919,903
- Issue date Feb 16, 2021
- Hepagene Therapeutics (HK) Limited
- Xiaodong Xu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic containing cyclopropyl FXR modulators
- Patent number 10,899,723
- Issue date Jan 26, 2021
- Hepagene Therapeutics (HK) Limited
- Xiaodong Xu
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
LIGAND CONJUGATES FOR DELIVERY OF THERAPEUTICALLY ACTIVE AGENTS
- Publication number 20240392289
- Publication date Nov 28, 2024
- Hepagene Therapeutics (HK) Limited
- Xiaodong Xu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
GLUCAGON-LIKE PEPTIDE-1 RECEPTOR MODULATORS AND USES THEREOF
- Publication number 20240382471
- Publication date Nov 21, 2024
- Hepagene Therapeutics (HK) Limited
- Xiaodong Xu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHENYLDIHYDROPYRIMIDINE COMPOUND AND USE THEREOF
- Publication number 20240246978
- Publication date Jul 25, 2024
- HEPAGENE THERAPEUTICS (HK) LIMITED
- Dongdong Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MNK INHIBITORS
- Publication number 20240092799
- Publication date Mar 21, 2024
- Hepagene Therapeutics (HK) Limited
- Cheng MO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC THR-B RECEPTOR AGONIST COMPOUND AND PREPARATION METHOD...
- Publication number 20220298187
- Publication date Sep 22, 2022
- Hepagene Therapeutics (HK) Limited
- Shanghai Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BIVALENT ANTAGONISTS OF INHIBITORS OF APOPTOSIS PROTEINS
- Publication number 20220220152
- Publication date Jul 14, 2022
- Hepagene Therapeutics (HK) Limited
- Xiaodong XU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DIMERIC PEPTIDE INHIBITORS OF APOPTOSIS PROTEINS
- Publication number 20210371459
- Publication date Dec 2, 2021
- Hepagene Therapeutics (HK) Limited
- Xiaodong XU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OXAZOLE AND THIAZOLE DERIVATIVES AS INHIBITORS OF ASK1
- Publication number 20210179600
- Publication date Jun 17, 2021
- Hepagene Therapeutics (HK) Limited
- Xiaodong Xu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AS FXR MODULATORS
- Publication number 20210079006
- Publication date Mar 18, 2021
- Hepagene Therapeutics (HK) Limited
- Xiaodong Xu
- C07 - ORGANIC CHEMISTRY

Hepagene Therapeutics (HK) Limited

Organization

Patents Grantslast 30 patents

Urea derivatives as inhibitors of ASK1

Nitrogen-containing heterocyclic compounds as FXR modulators

Heterocyclic containing cyclopropyl FXR modulators

Patents Applicationslast 30 patents

LIGAND CONJUGATES FOR DELIVERY OF THERAPEUTICALLY ACTIVE AGENTS

GLUCAGON-LIKE PEPTIDE-1 RECEPTOR MODULATORS AND USES THEREOF

PHENYLDIHYDROPYRIMIDINE COMPOUND AND USE THEREOF

MNK INHIBITORS

HETEROCYCLIC THR-B RECEPTOR AGONIST COMPOUND AND PREPARATION METHOD...

BIVALENT ANTAGONISTS OF INHIBITORS OF APOPTOSIS PROTEINS

DIMERIC PEPTIDE INHIBITORS OF APOPTOSIS PROTEINS

OXAZOLE AND THIAZOLE DERIVATIVES AS INHIBITORS OF ASK1

NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AS FXR MODULATORS

Trademarklast 30 trademarks